News

pharmaphorum
pharmaphorum.com > rd > redefining-drug-discovery-moroccos-biotech-strategy-infectious-and-chronic-diseases

Redefining drug discovery: Morocco’s biotech strategy for infectious and chronic diseases

11+ hour, 22+ min ago  (348+ words) Africa's healthcare systems continue to face significant economic and epidemiological pressures. A high burden of infectious diseases coexists with a rapid rise in non-communicable diseases such as diabetes, cancer, and cardiovascular conditions." For example, in 2024 malaria accounted for an estimated…...

pharmaphorum
pharmaphorum.com > patients > reframing-obesity-beyond-stigma-and-simplicity

Reframing obesity beyond stigma and simplicity

13+ hour, 22+ min ago  (678+ words) Bringing together clinicians, researchers, patient advocates, and industry voices, the event marked the beginning of a broader effort to rethink how obesity is discussed " and, crucially, how people living with it are treated. The scale of the issue at hand…...

pharmaphorum
pharmaphorum.com > news > threat-trumps-pharma-tariffs-looms-again

Threat of Trump's pharma tariffs looms again

12+ hour, 42+ min ago  (426+ words) The US federal government is said to be preparing to announce tariffs of up to 100% on some pharmaceutical imports, focusing on companies that have not signed pricing deals with the Trump administration. A Bloomberg report, citing people familiar with the…...

pharmaphorum
pharmaphorum.com > news > az-claims-another-win-imfinzi-frontline-liver-cancer

AZ claims another win for Imfinzi in frontline liver cancer

11+ hour, 41+ min ago  (567+ words) AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme. The new results come from the EMERALD-3 study, testing a combination of PD-L1 inhibitor Imfinzi (durvalumab) with AZ's CTLA4 inhibitor…...

pharmaphorum
pharmaphorum.com > digital > webinar-wrap-how-pharma-can-leverage-ai-driven-synthetic-personas

Webinar wrap-up: How pharma can leverage AI-driven synthetic personas

14+ hour, 19+ min ago  (922+ words) In a recent webinar sponsored by Lumanity " Using AI-driven synthetic personas to take your insights further " Damian Eade, Technology Transformation Officer, Insight, at Lumanity and St'phane Lebrat, Global Insights and Analytics Director at Takeda, discussed how, as AI continues to…...

pharmaphorum
pharmaphorum.com > news > alzheimers-biotech-korsana-go-public-reverse-merger

Alzheimer's biotech Korsana to go public via reverse merger

14+ hour, 12+ min ago  (508+ words) Korsana Biosciences only emerged onto the scene a few weeks ago, but is already planning to go public to raise funds for its Alzheimer's disease candidate. The start-up will achieve that through a reverse merger with Cyclerion Therapeutics, a Nasdaq-listed…...

pharmaphorum
pharmaphorum.com > news > dna-testing-can-help-right-racial-imbalance-breast-cancer

DNA testing can help right racial imbalance in breast cancer

1+ day, 7+ hour ago  (497+ words) Routine genomic testing could correct well-established disparities in breast cancer survival rates between white and black women, according to a new study. Black women have a 5% lower incidence of breast cancer compared to white women in the US, but have…...

pharmaphorum
pharmaphorum.com > event > woma-2025-steering-future-pharma-strategy

WOMA 2025: Steering the Future of Pharma Strategy

1+ day, 10+ hour ago  (217+ words) The global pharmaceutical industry is navigating more than just technological disruption; it is facing a fundamental redefinition of its socio-economic role. In a market shaped by intensifying regulatory pressures and the imperative for hyper-personalised medicine, value no longer resides solely…...

pharmaphorum
pharmaphorum.com > rd > human-behaviour-cancer-screening-trials-variable-goes-unmeasured

Human behaviour in cancer screening trials: A variable that goes unmeasured

1+ day, 10+ hour ago  (385+ words) Cancer screening guidelines " which tests to use, when to begin screening, how often to screen " are built on the evidence generated by clinical trials. That evidence is typically presented as a question: "Does earlier detection improve outcomes?" The clinical research…...

Google News
pharmaphorum.com > news > ema-seeks-input-virtual-alternative-animal-test

Google News

1+ day, 10+ hour ago  (9+ words) EMA seeks input on virtual alternative to animal test'pharmaphorum...